Grant: CIHR Fellowship
University of Toronto
$135,000.00
Modulating the function of SCF ubiquitin ligases through ubiquitin-based binders
FY 2012-13
Summary
The ubiquitin proteasome system is responsible for timely degradation of proteins inside the cell, which is absolutely critical for proper cellular function. Through a series of enzymatic steps, a small protein called ubiquitin is attached to other proteins, marking them for degradation by a large complex of proteins called the proteasome. Recently, it has become apparent that components of the ubiquitin proteasome system are deregulated in many cancers, making them attractive targets for cancer therapy. This has been validated by successful treatment of multiple myeloma with Bortezomib, a drug which prevents the proteasome from functioning normally. The clinical success of this drug, which has a general effect on the proteasome, suggests that a more targeted approach in which the function of specific components of the ubiquitin proteasome system are modulated could result in even better therapeutic action with less side effects. Of particular interest is targeting a group of enzymes called E3 ligases, which mediate the attachment of ubiquitin to the proteins bound for degradation, thus acting as specificity factors in the ubiquitin proteasome system. The main goal of my project is to develop protein-based binders to E3 ligases, with the goal of either preventing or enhancing their function. These protein modulators will provide tools for better understanding E3 ligase biology and perhaps pave way for the development of therapeutic drugs.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
270042
Name
Gorelik Maryna
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Modulating the function of SCF ubiquitin ligases through ubiquitin-based binders
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Combinatorial Libraries; E3 Ubiquitin Ligase; F-Box Protein; High Throughput Screening; Phage Display; Protein Degradation; Scf Ubiquitin Ligase; Structural Analysis; Ubiquitin Proteasome Pathway; Ubiquitin-Based Inhibitors/Activators
Abstract
The ubiquitin proteasome system is responsible for timely degradation of proteins inside the cell, which is absolutely critical for proper cellular function. Through a series of enzymatic steps, a small protein called ubiquitin is attached to other proteins, marking them for degradation by a large complex of proteins called the proteasome. Recently, it has become apparent that components of the ubiquitin proteasome system are deregulated in many cancers, making them attractive targets for cancer therapy. This has been validated by successful treatment of multiple myeloma with Bortezomib, a drug which prevents the proteasome from functioning normally. The clinical success of this drug, which has a general effect on the proteasome, suggests that a more targeted approach in which the function of specific components of the ubiquitin proteasome system are modulated could result in even better therapeutic action with less side effects. Of particular interest is targeting a group of enzymes called E3 ligases, which mediate the attachment of ubiquitin to the proteins bound for degradation, thus acting as specificity factors in the ubiquitin proteasome system. The main goal of my project is to develop protein-based binders to E3 ligases, with the goal of either preventing or enhancing their function. These protein modulators will provide tools for better understanding E3 ligase biology and perhaps pave way for the development of therapeutic drugs.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gorelik, Maryna
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~